Clinical Trials Market Size, Share, Industry Growth, Analysis and Forecast 2022-2028

The global clinical trials market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period.  The key factors that are contributing to the market growth are the adoption of several strategies by companies operating in the market for clinical trials market. For instance,

  • In June 2022, Walgreens launched its clinical trial business to increase access and retention in sponsor-led drug development research and redefine the patient experience. The company with this expansion is rapidly scaling three portfolio-integrated, patient-centric.

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/clinical-trials-market

  • In March 2022, CCT Research added a new innovative Decentralized Clinical Trial (DCT) team, to expand its reach and management of clinical trials by providing expert support to all subjects and sites. DCT is focused on supporting a positive subject experience and delivering exceptional quality data.
  • In April 2021, Calyx has launched Calyx CTMS v15.0, an advanced clinical trial management system that reduces risk and improves efficiencies in clinical development. It is Microsoft’s Azure cloud technology that simplifies the oversight of clinical trial operations and improves data quality.
  • In April 2021, Parexel and Veeva Systems have collaborated to accelerate clinical trials through technology and process innovation. In this new partnership, Parexel is dependent on Veeva’s suite of clinical operations applications, such as Veeva Vault eTMF, Vault CTMS, Vault Study Startup, and Veeva Vault CDMS for clinical data management.
  • In April 2021, Cofactor Genomics has began the first multicenter clinical trial of its OncoPrism immunotherapy response prediction assay, which is developed using the company’s proprietary immune modeling technology.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028
  • Segment Covered- 

o          By Phase

o          By Study Design

o          By Therapeutic Area

o          By Sponsor Outlook

  • Regions Covered-

o          North America

o          Europe

o          Asia-Pacific

o          Rest of the World

  • Competitive Landscape- AccuLab Life Sciences, Charles River Laboratories International, Inc., Eli Lilly and Co., Labcorp, Parexel International GmbH, Pfizer Inc., WuXi AppTec Co., Ltd., and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Clinical Trials Market Report Segment

By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design

  • Interventional
  • Observational
  • Expanded Access

By Therapeutic Area

  • Autoimmune Disease
  • Oncology
  • Cardiology
  • Infectious Disease
  • Dermatology
  • Ophthalmology
  • Others (Women’s Health, Genetic Diseases, and Immunology)

By Sponsor Outlook

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others (Academic Medical Centers, Industry-sponsored)

A full report of Clinical Trials Market is available at: https://www.omrglobal.com/industry-reports/clinical-trials-market

Clinical Trials Market– Segment by Region

North America          

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific   

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America

Company Profiles

  • AccuLab Life Sciences
  • BioAgile Therapeutics Pvt Ltd.
  • Celerion
  • Clario
  • Dove Quality Solutions Ltd.
  • Firma Clinical Research (Firma)
  • Frontage Laboratories, Inc.
  • Geneticist Inc
  • ICON plc
  • IQVIA
  • Linical Americas
  • Medpace, Inc.
  • Novo Nordisk A/S
  • Novotech

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research